1887

Abstract

AIDS, caused by the retroviruses human immunodeficiency virus type 1 and type 2 (HIV-1 and HIV-2), has reached pandemic proportions. Therefore, it is critical to understand how HIV causes AIDS so that appropriate therapies can be formulated. Primarily, HIV infects and kills CD4 T lymphocytes, which function as regulators and amplifiers of the immune response. In the absence of effective anti-retroviral therapy, the hallmark decrease in CD4 T lymphocytes during AIDS results in a weakened immune system, impairing the body's ability to fight infections or certain cancers such that death eventually ensues. The major mechanism for CD4 T cell depletion is programmed cell death (apoptosis), which can be induced by HIV through multiple pathways. Death of HIV-infected cells can result from the propensity of infected lymphocytes to form short-lived syncytia or from an increased susceptibility of the cells to death. However, the apoptotic cells appear to be primarily uninfected bystander cells and are eradicated by two different mechanisms: either a Fas-mediated mechanism during activation-induced cell death (AICD), or as a result of HIV proteins (Tat, gp120, Nef, Vpu) released from infected cells stimulating apoptosis in uninfected bystander cells. There is also evidence that as AIDS progresses cytokine dysregulation occurs, and the overproduction of type-2 cytokines (IL-4, IL-10) increases susceptibility to AICD whereas type-1 cytokines (IL-12, IFN-) may be protective. Clearly there are multiple causes of CD4 T lymphocyte apoptosis in AIDS and therapies that block or decrease that death could have significant clinical benefit.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.19110-0
2003-07-01
2021-01-16
Loading full text...

Full text loading...

/deliver/fulltext/jgv/84/7/vir841649.html?itemId=/content/journal/jgv/10.1099/vir.0.19110-0&mimeType=html&fmt=ahah

References

  1. Adachi Y., Oyaizu N., Than S., McCloskey T. W., Pahwa S.. 1996; IL-2 rescues in vitro lymphocyte apoptosis in patients with HIV infection: correlation with its ability to block culture-induced down-modulation of Bcl-2. J Immunol157:4184–4193
    [Google Scholar]
  2. Akari H., Bour S., Kao S., Adachi A., Strebel K.. 2001; The human immunodeficiency virus type 1 accessory protein Vpu induces apoptosis by suppressing the nuclear factor κ B-dependent expression of antiapoptotic factors. J Exp Med194:1299–1311
    [Google Scholar]
  3. Akbar A. N., Salmon M., Janossy G.. 1994; Role of bcl-2 and apoptosis in viral infections. Int Arch Allergy Immunol105:359–362
    [Google Scholar]
  4. Alam A., Cohen L. Y., Aouad S., Sekaly R. P.. 1999; Early activation of caspases during T lymphocyte stimulation results in selective substrate cleavage in nonapoptotic cells. J Exp Med190:1879–1890
    [Google Scholar]
  5. Algeciras A., Dockrell D. H., Lynch D. H., Paya C. V.. 1998; CD4 regulates susceptibility to Fas ligand- and tumor necrosis factor-mediated apoptosis. J Exp Med187:711–720
    [Google Scholar]
  6. Algeciras-Schimnich A., Vlahakis S. R., Villasis-Keever A., Gomez T., Heppelmann C. J., Bou G., Paya C. V.. 2002; CCR5 mediates Fas- and caspase-8 dependent apoptosis of both uninfected and HIV infected primary human CD4 T cells. AIDS16:1467–1478
    [Google Scholar]
  7. Alimonti J. B., Shi L., Baijal P. K., Greenberg A. H.. 2001; Granzyme B induces BID-mediated cytochrome c release and mitochondrial permeability transition. J Biol Chem276:6974–6982
    [Google Scholar]
  8. Aries S. P., Schaaf B., Muller C., Dennin R. H., Dalhoff K.. 1995; Fas (CD95) expression on CD4+ T cells from HIV-infected patients increases with disease progression. J Mol Med73:591–593
    [Google Scholar]
  9. Arthos J., Cicala C., Selig S. M.. 10 other authors 2002; The role of the CD4 receptor versus HIV coreceptors in envelope-mediated apoptosis in peripheral blood mononuclear cells. Virology292:98–106
    [Google Scholar]
  10. Azad A. A.. 2000; Could Nef and Vpr proteins contribute to disease progression by promoting depletion of bystander cells and prolonged survival of HIV-infected cells?. Biochem Biophys Res Commun267:677–685
    [Google Scholar]
  11. Badley A. D., Dockrell D. H., Algeciras A.. 10 other authors 1998; In vivo analysis of Fas/FasL interactions in HIV-infected patients. J Clin Invest102:79–87
    [Google Scholar]
  12. Badley A. D., Parato K., Cameron D. W.. 7 other authors 1999; Dynamic correlation of apoptosis and immune activation during treatment of HIV infection. Cell Death Differ6:420–432
    [Google Scholar]
  13. Banda N. K., Bernier J., Kurahara D. K., Kurrle R., Haigwood N., Sekaly R. P., Finkel T. H.. 1992; Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis. J Exp Med176:1099–1106
    [Google Scholar]
  14. Bartz S. R., Emerman M.. 1999; Human immunodeficiency virus type 1 Tat induces apoptosis and increases sensitivity to apoptotic signals by up-regulating FLICE/caspase-8. J Virol73:1956–1963
    [Google Scholar]
  15. Baumler C. B., Bohler T., Herr I., Benner A., Krammer P. H., Debatin K. M.. 1996; Activation of the CD95 (APO-1/Fas) system in T cells from human immunodeficiency virus type-1-infected children. Blood88:1741–1746
    [Google Scholar]
  16. Blanco J., Barretina J., Ferri K. F.. 7 other authors 2003; Cell-surface-expressed HIV-1 envelope induces the death of CD4 T cells during GP41-mediated hemifusion-like events. Virology305:318–329
    [Google Scholar]
  17. Borthwick N. J., Lowdell M., Salmon M., Akbar A. N.. 2000; Loss of CD28 expression on CD8+ T cells is induced by IL-2 receptor gamma chain signalling cytokines and type I IFN, and increases susceptibility to activation-induced apoptosis. Int Immunol12:1005–1013
    [Google Scholar]
  18. Bretscher P. A.. 1999; A two-step, two-signal model for the primary activation of precursor helper T cells. Proc Natl Acad Sci U S A96:185–190
    [Google Scholar]
  19. Budihardjo I., Oliver H., Lutter M., Luo X., Wang X.. 1999; Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol15:269–290
    [Google Scholar]
  20. Capobianchi M. R.. 1996; Induction of lymphomonocyte activation by HIV-1 glycoprotein gp120. Possible role in AIDS pathogenesis. J Biol Regul Homeost Agents10:83–91
    [Google Scholar]
  21. Casella C. R., Rapaport E. L., Finkel T. H.. 1999; Vpu increases susceptibility of human immunodeficiency virus type 1-infected cells to fas killing. J Virol73:92–100
    [Google Scholar]
  22. Chang H. C., Samaniego F., Nair B. C., Buonaguro L., Ensoli B.. 1997; HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region. AIDS11:1421–1431
    [Google Scholar]
  23. Chen D., Wang M., Zhou S., Zhou Q.. 2002; HIV-1 Tat targets microtubules to induce apoptosis, a process promoted by the pro-apoptotic Bcl-2 relative Bim. EMBO J21:6801–6810
    [Google Scholar]
  24. Chougnet C., Thomas E., Landay A. L., Kessler H. A., Buchbinder S., Scheer S., Shearer G. M.. 1998; CD40 ligand and IFN- γ synergistically restore IL-12 production in HIV-infected patients. Eur J Immunol28:646–656
    [Google Scholar]
  25. Cicala C., Arthos J., Ruiz M., Vaccarezza M., Rubbert A., Riva A., Wildt K., Cohen O., Fauci A. S.. 1999; Induction of phosphorylation and intracellular association of CC chemokine receptor 5 and focal adhesion kinase in primary human CD4+ T cells by macrophage-tropic HIV envelope. J Immunol163:420–426
    [Google Scholar]
  26. Cicala C., Arthos J., Rubbert A., Selig S., Wildt K., Cohen O. J., Fauci A. S.. 2000; HIV-1 envelope induces activation of caspase-3 and cleavage of focal adhesion kinase in primary human CD4+ T cells. Proc Natl Acad Sci U S A97:1178–1183
    [Google Scholar]
  27. Clark S. J., Saag M. S., Decker W. D., Campbell-Hill S., Roberson J. L., Veldkamp P. J., Kappes J. C., Hahn B. H., Shaw G. M.. 1991; High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection. New Engl J Med324:954–960
    [Google Scholar]
  28. Clerici M., Shearer G. M.. 1994; The Th1-Th2 hypothesis of HIV infection: new insights. Immunol Today15:575–581
    [Google Scholar]
  29. Clerici M., Sarin A., Berzofsky J. A.. 10 other authors 1996; Antigen-stimulated apoptotic T-cell death in HIV infection is selective for CD4+ T cells, modulated by cytokines and effected by lymphotoxin. AIDS10:603–611
    [Google Scholar]
  30. Cohen P. L., Eisenberg R. A.. 1992; The lpr and gld genes in systemic autoimmunity: life and death in the Fas lane. Immunol Today13:427–428
    [Google Scholar]
  31. Conti L., Rainaldi G., Matarrese P.. 7 other authors 1998; The HIV-1 vpr protein acts as a negative regulator of apoptosis in a human lymphoblastoid T cell line: possible implications for the pathogenesis of AIDS. J Exp Med187:403–413
    [Google Scholar]
  32. Copeland K. F., Heeney J. L.. 1996; T helper cell activation and human retroviral pathogenesis. Microbiol Rev60:722–742
    [Google Scholar]
  33. Crise B., Buonocore L., Rose J. K.. 1990; CD4 is retained in the endoplasmic reticulum by the human immunodeficiency virus type 1 glycoprotein precursor. J Virol64:5585–5593
    [Google Scholar]
  34. Daar E. S., Moudgil T., Meyer R. D., Ho D. D.. 1991; Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. New Engl J Med324:961–964
    [Google Scholar]
  35. Dockrell D. H., Badley A. D., Algeciras-Schimnich A., Simpson M., Schut R., Lynch D. H., Paya C. V.. 1999; Activation-induced CD4+ T cell death in HIV-positive individuals correlates with Fas susceptibility, CD4+ T cell count, and HIV plasma viral copy number. AIDS Res Hum Retroviruses15:1509–1518
    [Google Scholar]
  36. Embretson J., Zupancic M., Ribas J. L., Burke A., Racz P., Tenner-Racz K., Haase A. T.. 1993; Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature362:359–362
    [Google Scholar]
  37. Ensoli B., Barillari G., Salahuddin S. Z., Gallo R. C., Wong-Staal F.. 1990; Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature345:84–86
    [Google Scholar]
  38. Esser M. T., Bess J. W. Jr, Suryanarayana K., Chertova E., Marti D., Carrington M., Arthur L. O., Lifson J. D.. 2001; Partial activation and induction of apoptosis in CD4+ and CD8+ T lymphocytes by conformationally authentic noninfectious human immunodeficiency virus type 1. J Virol75:1152–1164
    [Google Scholar]
  39. Estaquier J., Idziorek T., Zou W., Emilie D., Farber C. M., Bourez J. M., Ameisen J. C.. 1995; T helper type 1/T helper type 2 cytokines and T cell death: preventive effect of interleukin 12 on activation-induced and CD95 (FAS/APO-1)-mediated apoptosis of CD4+ T cells from human immunodeficiency virus-infected persons. J Exp Med182:1759–1767
    [Google Scholar]
  40. Estaquier J., Tanaka M., Suda T., Nagata S., Golstein P., Ameisen J. C.. 1996; Fas-mediated apoptosis of CD4+ and CD8+ T cells from human immunodeficiency virus-infected persons: differential in vitro preventive effect of cytokines and protease antagonists. Blood87:4959–4966
    [Google Scholar]
  41. Evan G., Littlewood T.. 1998; A matter of life and cell death. Science281:1317–1322
    [Google Scholar]
  42. Everett H., McFadden G.. 1999; Apoptosis: an innate immune response to virus infection. Trends Microbiol7:160–165
    [Google Scholar]
  43. Fauci A. S.. 1988; The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science239:617–622
    [Google Scholar]
  44. Finkel T. H., Tudor-Williams G., Banda N. K., Cotton M. F., Curiel T., Monks C., Baba T. W., Ruprecht R. M., Kupfer A.. 1995; Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes. Nat Med1:129–134
    [Google Scholar]
  45. Fowke K. R., D'Amico R., Chernoff D. N., Pottage J. C. Jr, Benson C. A., Sha B. E., Kessler H. A., Landay A. L., Shearer G. M.. 1997; Immunologic and virologic evaluation after influenza vaccination of HIV- 1-infected patients. AIDS11:1013–1021
    [Google Scholar]
  46. Fowke K. R., Kaul R., Rosenthal K. L.. 9 other authors 2000; HIV-1-specific cellular immune responses among HIV-1-resistant sex workers. Immunol Cell Biol78:586–595
    [Google Scholar]
  47. Furtado M. R., Kingsley L. A., Wolinsky S. M.. 1995; Changes in the viral mRNA expression pattern correlate with a rapid rate of CD4+ T-cell number decline in human immunodeficiency virus type 1-infected individuals. J Virol69:2092–2100
    [Google Scholar]
  48. Galli G., Annunziato F., Cosmi L., Manetti R., Maggi E., Romagnani S.. 2001; Th1 and th2 responses, HIV-1 coreceptors and HIV-1 infection. J Biol Regul Homeost Agents15:308–313
    [Google Scholar]
  49. Gibellini D., Re M. C., Ponti C., Maldini C., Celeghini C., Cappellini A., La Placa M., Zauli G.. 2001; HIV-1 Tat protects CD4+ Jurkat T lymphoblastoid cells from apoptosis mediated by TNF-related apoptosis-inducing ligand. Cell Immunol207:89–99
    [Google Scholar]
  50. Giri J. G., Anderson D. M., Kumaki S., Park L. S., Grabstein K. H., Cosman D.. 1995; IL-15, a novel T cell growth factor that shares activities and receptor components with IL-2. J Leukoc Biol57:763–766
    [Google Scholar]
  51. Golstein P.. 1998; Cell death in us and others. Science281:1283
    [Google Scholar]
  52. Gonzalez M. E., Carrasco L.. 2001; Human immunodeficiency virus type 1 VPU protein affects Sindbis virus glycoprotein processing and enhances membrane permeabilization. Virology279:201–209
    [Google Scholar]
  53. Gougeon M. L., Montagnier L.. 1993; Apoptosis in AIDS. Science260:1269–1270
    [Google Scholar]
  54. Gougeon M. L., Lecoeur H., Dulioust A., Enouf M. G., Crouvoiser M., Goujard C., Debord T., Montagnier L.. 1996; Programmed cell death in peripheral lymphocytes from HIV-infected persons: increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progression. J Immunol156:3509–3520
    [Google Scholar]
  55. Gross A.. 2001; BCL-2 proteins: regulators of the mitochondrial apoptotic program. IUBMB Life52:231–236
    [Google Scholar]
  56. Gummuluru S., Emerman M.. 1999; Cell cycle- and Vpr-mediated regulation of human immunodeficiency virus type 1 expression in primary and transformed T-cell lines. J Virol73:5422–5430
    [Google Scholar]
  57. Han X., Becker K., Degen H. J., Jablonowski H., Strohmeyer G.. 1996; Synergistic stimulatory effects of tumour necrosis factor α and interferon γ on replication of human immunodeficiency virus type 1 and on apoptosis of HIV-1-infected host cells. Eur J Clin Invest26:286–292
    [Google Scholar]
  58. Hanabuchi S., Koyanagi M., Kawasaki A.. 7 other authors 1994; Fas and its ligand in a general mechanism of T-cell-mediated cytotoxicity. Proc Natl Acad Sci U S A91:4930–4934
    [Google Scholar]
  59. Ho D. D., Neumann A. U., Perelson A. S., Chen W., Leonard J. M., Markowitz M.. 1995; Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature373:123–126
    [Google Scholar]
  60. Hober D., Benyoucef S., Delannoy A. S., de Groote D., Ajana F., Mouton Y., Wattre P.. 1996; High plasma level of soluble tumor necrosis factor receptor type II (sTNFRII) in asymptomatic HIV-1-infected patients. Infection24:213–217
    [Google Scholar]
  61. Hogan C. M., Hammer S. M.. 2001a; Host determinants in HIV infection and disease. Part 1: cellular and humoral immune responses. Ann Intern Med134:761–776
    [Google Scholar]
  62. Hogan C. M., Hammer S. M.. 2001b; Host determinants in HIV infection and disease. Part 2: genetic factors and implications for antiretroviral therapeutics. Ann Intern Med134:978–996
    [Google Scholar]
  63. Howcroft T. K., Strebel K., Martin M. A., Singer D. S.. 1993; Repression of MHC class I gene promoter activity by two-exon Tat of HIV. Science260:1320–1322
    [Google Scholar]
  64. Irmler M., Thome M., Hahne M.. 10 other authors 1997; Inhibition of death receptor signals by cellular FLIP. Nature388:190–195
    [Google Scholar]
  65. Jacotot E., Ferri K. F., El Hamel C.. 17 other authors 2001; Control of mitochondrial membrane permeabilization by adenine nucleotide translocator interacting with HIV-1 viral protein rR and Bcl-2. J Exp Med193:509–519
    [Google Scholar]
  66. Kabelitz D., Pohl T., Pechhold K.. 1995; T cell apoptosis triggered via the CD3/T cell receptor complex and alternative activation pathways. Curr Top Microbiol Immunol200:1–14
    [Google Scholar]
  67. Kalams S. A., Buchbinder S. P., Rosenberg E. S., Billingsley J. M., Colbert D. S., Jones N. G., Shea A. K., Trocha A. K., Walker B. D.. 1999; Association between virus-specific cytotoxic T-lymphocyte and helper responses in human immunodeficiency virus type 1 infection. J Virol73:6715–6720
    [Google Scholar]
  68. Kammerer R., Iten A., Frei P. C., Burgisser P.. 1996; Expansion of T cells negative for CD28 expression in HIV infection. Relation to activation markers and cell adhesion molecules, and correlation with prognostic markers. Med Microbiol Immunol (Berl)185:19–25
    [Google Scholar]
  69. Kasaian M. T., Leite-Morris K. A., Biron C. A.. 1991; The role of CD4+ cells in sustaining lymphocyte proliferation during lymphocytic choriomeningitis virus infection. J Immunol146:1955–1963
    [Google Scholar]
  70. Kennedy N. J., Kataoka T., Tschopp J., Budd R. C.. 1999; Caspase activation is required for T cell proliferation. J Exp Med190:1891–1896
    [Google Scholar]
  71. Kimata J. T., Kuller L., Anderson D. B., Dailey P., Overbaugh J.. 1999; Emerging cytopathic and antigenic simian immunodeficiency virus variants influence AIDS progression. Nat Med5:535–541
    [Google Scholar]
  72. Kinter A., Catanzaro A., Monaco J.. 12 other authors 1998; CC-chemokines enhance the replication of T-tropic strains of HIV-1 in CD4+ T cells: role of signal transduction. Proc Natl Acad Sci U S A95:11880–11885
    [Google Scholar]
  73. Koenig S., Conley A. J., Brewah Y. A.. other authors 1995; Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression. Nat Med1:330–336
    [Google Scholar]
  74. Korant B. D., Strack P., Frey M. W., Rizzo C. J.. 1998; A cellular anti-apoptosis protein is cleaved by the HIV-1 protease. Adv Exp Med Biol436:27–29
    [Google Scholar]
  75. Korsmeyer S. J., Wei M. C., Saito M., Weiler S., Oh K. J., Schlesinger P. H.. 2000; Pro-apoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome c. Cell Death Differ7:1166–1173
    [Google Scholar]
  76. Kovacs J. A., Vogel S., Metcalf J. A.. 14 other authors 2001; Interleukin-2 induced immune effects in human immunodeficiency virus-infected patients receiving intermittent interleukin-2 immunotherapy. Eur J Immunol31:1351–1360
    [Google Scholar]
  77. Ledru E., Lecoeur H., Garcia S., Debord T., Gougeon M. L.. 1998; Differential susceptibility to activation-induced apoptosis among peripheral Th1 subsets: correlation with Bcl-2 expression and consequences for AIDS pathogenesis. J Immunol160:3194–3206
    [Google Scholar]
  78. Lehmann J., Alber G.. 1998; Murine leishmaniosis: a paradigm for the importance of T helper 1 and T helper 2 cells. Rev Sci Tech17:176–187
    [Google Scholar]
  79. Lehmann-Grube F., Lohler J., Utermohlen O., Gegin C.. 1993; Antiviral immune responses of lymphocytic choriomeningitis virus-infected mice lacking CD8+ T lymphocytes because of disruption of the beta 2-microglobulin gene. J Virol67:332–339
    [Google Scholar]
  80. Lenardo M., Chan K. M., Hornung F., McFarland H., Siegel R., Wang J., Zheng L.. 1999; Mature T lymphocyte apoptosis – immune regulation in a dynamic and unpredictable antigenic environment. Annu Rev Immunol17:221–253
    [Google Scholar]
  81. Levy J. A.. 1993; Pathogenesis of human immunodeficiency virus infection. Microbiol Rev57:183–289
    [Google Scholar]
  82. Li C. J., Friedman D. J., Wang C., Metelev V., Pardee A. B.. 1995; Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Science268:429–431
    [Google Scholar]
  83. Li-Weber M., Laur O., Dern K., Krammer P. H.. 2000; T cell activation-induced and HIV tat-enhanced CD95(APO-1/Fas) ligand transcription involves NF- κ B. Eur J Immunol30:661–670
    [Google Scholar]
  84. Los M., Wesselborg S., Schulze-Osthoff K.. 1999; The role of caspases in development, immunity and apoptotic signal transduction: lessons from knockout mice. Immunity10:629–639
    [Google Scholar]
  85. Lukacher A. E., Braciale V. L., Braciale T. J.. 1984; In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific. J Exp Med160:814–826
    [Google Scholar]
  86. Macaubas C., Sly P. D., Burton P.. 7 other authors 1999; Regulation of T-helper cell responses to inhalant allergen during early childhood. Clin Exp Allergy29:1223–1231
    [Google Scholar]
  87. Maloy K. J., Burkhart C., Junt T. M., Odermatt B., Oxenius A., Piali L., Zinkernagel R. M., Hengartner H.. 2000; CD4+ T cell subsets during virus infection. Protective capacity depends on effector cytokine secretion and on migratory capability. J Exp Med191:2159–2170
    [Google Scholar]
  88. Mann D. A., Frankel A. D.. 1991; Endocytosis and targeting of exogenous HIV-1 Tat protein. EMBO J10:1733–1739
    [Google Scholar]
  89. Marschner S., Hunig T., Cambier J. C., Finkel T. H.. 2002; Ligation of human CD4 interferes with antigen-induced activation of primary T cells. Immunol Lett82:131–139
    [Google Scholar]
  90. Matloubian M., Concepcion R. J., Ahmed R.. 1994; CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection. J Virol68:8056–8063
    [Google Scholar]
  91. Murray R. J., Kurilla M. G., Brooks J. M., Thomas W. A., Rowe M., Kieff E., Rickinson A. B.. 1992; Identification of target antigens for the human cytotoxic T cell response to Epstein–Barr virus (EBV): implications for the immune control of EBV-positive malignancies. J Exp Med176:157–168
    [Google Scholar]
  92. Nagata S., Suda T.. 1995; Fas and Fas ligand: lpr and gld mutations. Immunol Today16:39–43
    [Google Scholar]
  93. Naora H., Gougeon M. L.. 1999; Interleukin-15 is a potent survival factor in the prevention of spontaneous but not CD95-induced apoptosis in CD4 and CD8 T lymphocytes of HIV-infected individuals. Correlation with its ability to increase BCL-2 expression. Cell Death Differ6:1002–1011
    [Google Scholar]
  94. New D. R., Ma M., Epstein L. G., Nath A., Gelbard H. A.. 1997; Human immunodeficiency virus type 1 Tat protein induces death by apoptosis in primary human neuron cultures. J Neurovirol3:168–173
    [Google Scholar]
  95. Nie Z., Phenix B. N., Lum J. J., Alam A., Lynch D. H., Beckett B., Krammer P. H., Sekaly R. P., Badley A. D.. 2002; HIV-1 protease processes procaspase 8 to cause mitochondrial release of cytochrome c, caspase cleavage and nuclear fragmentation. Cell Death Differ9:1172–1184
    [Google Scholar]
  96. Nishimura Y., Hosokawa T., Hosono M., Baba M., Hosokawa M.. 2002; Insufficient interleukin-2 production from splenic CD4+ T cells causes impaired cell proliferation and early apoptosis in SAMP1, a strain of senescence-accelerated mouse. Immunology107:190–198
    [Google Scholar]
  97. O'Flaherty E., Wong W. K., Pettit S. J., Seymour K., Ali S., Kirby J. A.. 2000; Regulation of T-cell apoptosis: a mixed lymphocyte reaction model. Immunology100:289–299
    [Google Scholar]
  98. Ohmi Y., Shiku H., Nishimura T.. 1999; Tumor-specific targeting of T helper type 1 (Th1) cells by anti-CD3 x anti-c-ErbB-2 bispecific antibody. Cancer Immunol Immunother48:456–462
    [Google Scholar]
  99. Okada H., Takei R., Tashiro M.. 1997; HIV-1 Nef protein-induced apoptotic cytolysis of a broad spectrum of uninfected human blood cells independently of CD95(Fas. FEBS Lett414:603–606
    [Google Scholar]
  100. Okada H., Morikawa S., Tashiro M.. 1998; HIV-1 Nef binding protein expressed on the surface of murine blood cells. Med Microbiol Immunol (Berl)186201–207
    [Google Scholar]
  101. Oyaizu N., McCloskey T. W., Than S., Hu R., Kalyanaraman V. S., Pahwa S.. 1994; Cross-linking of CD4 molecules upregulates Fas antigen expression in lymphocytes by inducing interferon-gamma and tumor necrosis factor- α secretion. Blood84:2622–2631
    [Google Scholar]
  102. Perelson A. S., Neumann A. U., Markowitz M., Leonard J. M., Ho D. D.. 1996; HIV-1 dynamics in vivo : virion clearance rate, infected cell life-span, and viral generation time. Science271:1582–1586
    [Google Scholar]
  103. Phenix B. N., Badley A. D.. 2002; Influence of mitochondrial control of apoptosis on the pathogenesis, complications and treatment of HIV infection. Biochimie84:251–264
    [Google Scholar]
  104. Piatak M. Jr, Saag M. S., Yang L. C., Clark S. J., Kappes J. C., Luk K. C., Hahn B. H., Shaw G. M., Lifson J. D.. 1993; High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science259:1749–1754
    [Google Scholar]
  105. Pugliese A., Cantamessa C., Saini A., Piragino A., Gennero L., Martini C., Torre D.. 1999; Effects of the exogenous Nef protein on HIV-1 target cells. Cell Biochem Funct17:183–192
    [Google Scholar]
  106. Re M., Gibellini D., Aschbacher R., Vignoli M., Furlini G., Ramazzotti E., Bertolaso L., La Placa M.. 1998; High levels of HIV-1 replication show a clear correlation with downmodulation of Bcl-2 protein in peripheral blood lymphocytes of HIV-1-seropositive subjects. J Med Virol56:66–73
    [Google Scholar]
  107. Richman D. D., Bozzette S. A.. 1994; The impact of the syncytium-inducing phenotype of human immunodeficiency virus on disease progression. J Infect Dis169:968–974
    [Google Scholar]
  108. Robinson D. S., Hamid Q., Jacobson M., Ying S., Kay A. B., Durham S. R.. 1993; Evidence for Th2-type T helper cell control of allergic disease in vivo Springer Semin Immunopathol;1517–27
    [Google Scholar]
  109. Rosenberg E. S., Walker B. D.. 1998; HIV type 1-specific helper T cells: a critical host defense. AIDS Res Hum Retroviruses14 (Suppl. 2):S143–147
    [Google Scholar]
  110. Rosenberg E. S., Billingsley J. M., Caliendo A. M., Boswell S. L., Sax P. E., Kalams S. A., Walker B. D.. 1997; Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science278:1447–1450
    [Google Scholar]
  111. Roumier T., Vieira H. L., Castedo M.. 8 other authors 2002; The C-terminal moiety of HIV-1 Vpr induces cell death via a caspase-independent mitochondrial pathway. Cell Death Differ9:1212–1219
    [Google Scholar]
  112. Saha K., Bentsman G., Chess L., Volsky D. J.. 1998; Endogenous production of β -chemokines by CD4+, but not CD8+, T-cell clones correlates with the clinical state of human immunodeficiency virus type 1 (HIV-1)-infected individuals and may be responsible for blocking infection with non-syncytium-inducing HIV-1 in vitro . J Virol72:876–881
    [Google Scholar]
  113. Salghetti S., Mariani R., Skowronski J.. 1995; Human immunodeficiency virus type 1 Nef and p56lck protein-tyrosine kinase interact with a common element in CD4 cytoplasmic tail. Proc Natl Acad Sci U S A92:349–353
    [Google Scholar]
  114. Sastry K. J., Marin M. C., Nehete P. N., McConnell K., el-Naggar A. K., McDonnell T. J.. 1996; Expression of human immunodeficiency virus type I tat results in down-regulation of bcl-2 and induction of apoptosis in hematopoietic cells. Oncogene13:487–493
    [Google Scholar]
  115. Schirren C. A., Jung M., Worzfeld T.. 7 other authors 2000; Cytokine profile of liver- and blood-derived nonspecific T cells after liver transplantation: T helper cells type 1/0 lymphokines dominate in recurrent hepatitis C virus infection and rejection. Liver Transpl6:222–228
    [Google Scholar]
  116. Schwartz O., Marechal V., Le Gall S., Lemonnier F., Heard J. M.. 1996; Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat Med2:338–342
    [Google Scholar]
  117. Shaw G. M., Hahn B. H., Arya S. K., Groopman J. E., Gallo R. C., Wong-Staal F.. 1984; Molecular characterization of human T-cell leukemia (lymphotropic) virus type III in the acquired immune deficiency syndrome. Science226:1165–1171
    [Google Scholar]
  118. Silvestris F., Cafforio P., Frassanito M. A., Tucci M., Romito A., Nagata S., Dammacco F.. 1996; Overexpression of Fas antigen on T cells in advanced HIV-1 infection: differential ligation constantly induces apoptosis. AIDS10:131–141
    [Google Scholar]
  119. Silvestris F., Camarda G., Del Prete A., Tucci M., Dammacco F.. 1999; Nef protein induces differential effects in CD8+ cells from HIV-1- infected patients. Eur J Clin Invest29:980–991
    [Google Scholar]
  120. Somma F., Tuosto L., Montani M. S., Di Somma M. M., Cundari E., Piccolella E.. 2000; Engagement of CD4 before TCR triggering regulates both Bax- and Fas (CD95)-mediated apoptosis. J Immunol164:5078–5087
    [Google Scholar]
  121. Sousa A. E., Chaves A. F., Doroana M., Antunes F., Victorino R. M.. 1999; Early reduction of the over-expression of CD40L, OX40 and Fas on T cells in HIV-1 infection during triple anti-retroviral therapy: possible implications for lymphocyte traffic and functional recovery. Clin Exp Immunol116:307–315
    [Google Scholar]
  122. Srivastava R. K., Sasaki C. Y., Hardwick J. M., Longo D. L.. 1999; Bcl-2-mediated drug resistance: inhibition of apoptosis by blocking nuclear factor of activated T lymphocytes (NFAT)-induced Fas ligand transcription. J Exp Med190:253–265
    [Google Scholar]
  123. Strack P. R., Frey M. W., Rizzo C. J.. 7 other authors 1996; Apoptosis mediated by HIV protease is preceded by cleavage of Bcl-2. Proc Natl Acad Sci U S A93:9571–9576
    [Google Scholar]
  124. Strasser A., O'Connor L., Dixit V. M.. 2000; Apoptosis signaling. Annu Rev Biochem69:217–245
    [Google Scholar]
  125. Stylianou E., Yndestad A., Sikkeland L. I., Bjerkeli V., Damas J. K., Haug T., Eiken H. G., Aukrust P., Froland S. S.. 2002; Effects of interferon- α on gene expression of chemokines and members of the tumour necrosis factor superfamily in HIV-infected patients. Clin Exp Immunol130:279–285
    [Google Scholar]
  126. Suda T., Okazaki T., Naito Y., Yokota T., Arai N., Ozaki S., Nakao K., Nagata S.. 1995; Expression of the Fas ligand in cells of T cell lineage. J Immunol154:3806–3813
    [Google Scholar]
  127. Sylwester A., Murphy S., Shutt D., Soll D. R.. 1997; HIV-induced T cell syncytia are self-perpetuating and the primary cause of T cell death in culture. J Immunol158:3996–4007
    [Google Scholar]
  128. Tateyama M., Oyaizu N., McCloskey T. W., Than S., Pahwa S.. 2000; CD4 T lymphocytes are primed to express Fas ligand by CD4 cross-linking and to contribute to CD8 T-cell apoptosis via Fas/FasL death signaling pathway. Blood96:195–202
    [Google Scholar]
  129. Trillo-Pazos G., McFarlane-Abdulla E., Campbell I. C., Pilkington G. J., Everall I. P.. 2000; Recombinant nef HIV-IIIB protein is toxic to human neurons in culture. Brain Res864:315–326
    [Google Scholar]
  130. von Herrath M. G., Yokoyama M., Dockter J., Oldstone M. B., Whitton J. L.. 1996; CD4-deficient mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance to subsequent virus challenge. J Virol70:1072–1079
    [Google Scholar]
  131. Walker R. E., Spooner K. M., Kelly G.. 10 other authors 1996; Inhibition of immunoreactive tumor necrosis factor- α by a chimeric antibody in patients infected with human immunodeficiency virus type 1. J Infect Dis174:63–68
    [Google Scholar]
  132. Watanabe N., Yamaguchi T., Akimoto Y., Rattner J. B., Hirano H., Nakauchi H.. 2000; Induction of M-phase arrest and apoptosis after HIV-1 Vpr expression through uncoupling of nuclear and centrosomal cycle in HeLa cells. Exp Cell Res258:261–269
    [Google Scholar]
  133. Wei X., Ghosh S. K., Taylor M. E.. other authors 1995; Viral dynamics in human immunodeficiency virus type 1 infection. Nature373:117–122
    [Google Scholar]
  134. Westendorp M. O., Frank R., Ochsenbauer C., Stricker K., Dhein J., Walczak H., Debatin K. M., Krammer P. H.. 1995; Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature375:497–500
    [Google Scholar]
  135. WHO 2002; AIDS epidemic update 2002 UNAIDS;
    [Google Scholar]
  136. Willey R. L., Maldarelli F., Martin M. A., Strebel K.. 1992; Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4. J Virol66:7193–7200
    [Google Scholar]
  137. Wolf B. B., Green D. R.. 1999; Suicidal tendencies: apoptotic cell death by caspase family proteinases. J Biol Chem274:20049–20052
    [Google Scholar]
  138. Xu X. N., Laffert B., Screaton G. R., Kraft M., Wolf D., Kolanus W., Mongkolsapay J., McMichael A. J., Baur A. S.. 1999; Induction of Fas ligand expression by HIV involves the interaction of Nef with the T cell receptor zeta chain. J Exp Med189:1489–1496
    [Google Scholar]
  139. Yang Y., Dong B., Mittelstadt P. R., Xiao H., Ashwell J. D.. 2002; HIV Tat binds Egr proteins and enhances Egr-dependent transactivation of the Fas ligand promoter. J Biol Chem277:19482–19487
    [Google Scholar]
  140. Zagury D., Lachgar A., Chams V.. 10 other authors 1998; Interferon α and Tat involvement in the immunosuppression of uninfected T cells and C-C chemokine decline in AIDS. Proc Natl Acad Sci U S A95:3851–3856
    [Google Scholar]
  141. Zangerle R., Gallati H., Sarcletti M., Wachter H., Fuchs D.. 1994; Tumor necrosis factor α and soluble tumor necrosis factor receptors in individuals with human immunodeficiency virus infection. Immunol Lett41:229–234
    [Google Scholar]
  142. Zauli G., Gibellini D., Caputo A., Bassini A., Negrini M., Monne M., Mazzoni M., Capitani S.. 1995; The human immunodeficiency virus type-1 Tat protein upregulates Bcl-2 gene expression in Jurkat T-cell lines and primary peripheral blood mononuclear cells. Blood86:3823–3834
    [Google Scholar]
  143. Zauli G., Gibellini D., Secchiero P., Dutartre H., Olive D., Capitani S., Collette Y.. 1999; Human immunodeficiency virus type 1 Nef protein sensitizes CD4+ T lymphoid cells to apoptosis via functional upregulation of the CD95/CD95 ligand pathway. Blood93:1000–1010
    [Google Scholar]
  144. Zeevi A., Spichty K., Banas R.. 8 other authors 1999; Clinical significance of cytomegalovirus-specific T helper responses and cytokine production in lung transplant recipients. Intervirology42:291–300
    [Google Scholar]
  145. Zhang M., Li X., Pang X., Ding L., Wood O., Clouse K., Hewlett I., Dayton A. I.. 2001; Identification of a potential HIV-induced source of bystander-mediated apoptosis in T cells: upregulation of trail in primary human macrophages by HIV-1 tat. J Biomed Sci8:290–296
    [Google Scholar]
  146. Zimmermann K. C., Bonzon C., Green D. R.. 2001; The machinery of programmed cell death. Pharmacol Ther92:57–70
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.19110-0
Loading
/content/journal/jgv/10.1099/vir.0.19110-0
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error